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ffe.w!fs are shown in lhe 1aMQ. CVRrel was 3.2 * 0.7 before tntewenlton 
and 3.1 k 0.9 after 6 months. 
&nduwr Gwdence Ql CVRd by CVRrel Instead 01 fixed cti.off !ovets 
atlows lo fdent~fy pts wtm I IOW incidence 0t mstenos~s after CO~O~~V stenl 
0wlanlawn. 
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Pulmonary Artery cathetenzatron (PAC) has been assonafed ~IUI mcreased 
mottakly but its use tn Caf@ogenic Shock (CS) IS w&spread. The SHOCK 
Registn/ ts a P- database Of patients wrul suspected cs folIowIng 
AM. 1-1 evalua:e L?e impact of PAC. basalme vanebb. hamadynarma and 
outcomes m 567 patients wlao recewed PAC were compared to 2S3 patients 
managed mthoul PAC. A ‘pr~+wtsity scorn’’ for PAC pkcemenl was dewed 
fmm a log&c regression model usmg baseline Mnabfes and ad@sred mor- 
Iality rates were compared. Patfffs receiving PAC were signikanHy ywnger 
(67.5 f 11.4&7#.5 f 11.6yfs. p c 0.0001). w-en? more likefytobebansfera 
(46% vs 27%. p < 0.0001). had less prior MI (35 vs 48%. p = 0.0081 and 
developed CS later (7.8 vs 4.5 median hrs. p = 0.005). Atthough lowesl SBP 
(69 f 18 vs 69 f 19 mm. p = 0.816) and MI location were similar. pabents 
wxvlth PAC had increased HR (99 i 25 vs 69 i 28. p = 0.0001). SBP (92 * 21 
w77*20mm.p=~0.0001)and08P(55*15vs45r.20mm.p=0.0001) 
with more inotrope use and were more likely to undergo calh. PTCA. IABP 
and CABG (p < 0.0001) with decreased In hospllal mortality (56 vs 79%. p 
< 0.0001) bul no impact on LOS. Even after adfuslmg for baseline vanables 
(PAC pmpenstty) patients receiving PAC had lowered mortality (OR 0.458 
95% Cl 0.31-0.67. Chi-square 15.4, p = 0.0001). 
Conclusion: PAC use in suspected CS is associated with aggressive 
therapy and a lower in hospital mortality. Selection bias is ewdent but no 
harm associated with PAC was demonstrated. 
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Aueument o? P~tentlal lot Weaning From 
MechanIcal left Vontrkubr Support U~lng 
Qwmtltatlve Echocardlogmphy 
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~vinl.LVADe@aced:@&med&s 
D~~~~IcuI of suppod was lb * 21 
days. Meapu~?a ot mt&LV Mart aws Wi ares (EDAJ. v 
erea @?iAJ. ind hactwnal ar8il chcnca [FAC = (EDA - ESAlEDA) were 
me& dunng n@ LVAD fiow: 4.6 f 0.4 f&m and wnoy weanmg to h 
LVAD lbv. 1.9 + 0 9 Umin. jeven p(e had ~ucces~tul refnwal 01 LVAD 
(mchrdmg Ttwetec mwxnd in 1) and euwiverl lo ho-1 dtshatge. Five 
pts remelnad LVAD dependent. 4 dted vtthrn 7 days, 1 was hasrpfantad. 
Easekne LV FAC dO% w I tv&mvamt m LV FAC % J ~20% frmn hgh 
to low LVAD tlwr was predIctbe ot successful LVAD racnoval (p c 0.05). All 
LVADdependenfpt~cwMnofwtcmase FAC > 15% WIWI low LVAD Ilow 
w 0 Lv1D(lrwnlomap + 
l rv~-arovo 1 
Conctmm Ownmaiwe echo be useful to assess myocardfal re- 
covery II-I ph on LVAD s+rpporl and aid m me ckmcal denson Ior LVAD 
removal. 
4:30 
L-J 904 3 Gender and other Pmdk%om of kvtraaortlc Balloon 
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Backgrcund This p-e study exammed me c~mpl~catkms a zxxtated 
wnfh mntraaorl~c baflcun (IAB) counterpulsahon and the rofe of gender an the 
current em 
AeModp:Weevafuafed1.119~ percutaneovs IAB msedmns 
al Allegheny Umvefstty H-5. Hafmemann Dtwston from January 1993 
to June 1997 All patients were followed prospectiily Wcm a deify cllntcal 
evafuabon. M-r compkcatkms were defmed as balloon niplure. emboksm 
or kmb rsthemfa reqlnnng surgery. bleedtng requtnng transtunon. sysmmif 
Wection. or deam due to one of the above. 
ResuIfs There were 727 men and 392 women (age, 65 L 11 yrs.). 
~nctdence of cfiabates (27%). hypertension (52%). or penphafal v scular 
disease (8%) A total of 196 compfiiti~ns axwed and a map compke?km 
occurred m 126 ot 1,119 pallems (119b). Mutioaro logrsllc rcgressmn 
analysts ot age. cardtac Mex. b&y surface area (BSA). gender, diabetes 
and penpheal vasculaf disease (PVD) as covanates. ideWed PVD (felattve 
risk. RR = 4.1). female gender (RR = 2 3). and BSA (RR - 0.26 per m2) 
as Mependent predictors 01 a mafor compllcatlon. Defmlng ‘high risk”.. as 
women or pabents with BSA < 1.8 mZ. cardiac index -.2.2. dtabatas Or PVD. 
predicted 150 compllcattons smong 818 patter@. (18%) compared to 16 
complications among 301 ‘low risk’ patients (5%) (p -Z 0.0001). 
Conclunon: Despite reducficns in sizes of IAB and sheath. the cun-enl 
complication rare associated with mbaaortii counterpulsat!on remains high. 
Advances in IAB technology need to focus on Ihe ‘high risk’ Subset Of Pabents 
that incluti wor+,.l. or smaller pattents. and those tih PVD. 
